Category Archives: Top Market News

Adobe Gets a Hold Rating from Pivotal Research

Pivotal Research analyst Brian Wieser assigned a Hold rating to Adobe (NASDAQ: ADBE) today and set a price target of $162. The company’s shares opened today at $179.36, close to its 52-week high of $186.27. Wieser commented: “We raise our

Barclays Sticks to Their Hold Rating for Fair Isaac Corp

In a report released yesterday, Manav Patnaik from Barclays maintained a Hold rating on Fair Isaac Corp (NYSE: FICO), with a price target of $150. The company’s shares opened today at $155.09, close to its 52-week high of $159. According

Analysts Conflicted on These Technology Names: Verifone (NYSE: PAY) and Rapid7 (NASDAQ: RPD)

Analysts have been eager to weigh in on the Technology sector with new ratings on Verifone (NYSE: PAY) and Rapid7 (NASDAQ: RPD). Verifone (NYSE: PAY) Barclays analyst Darrin Peller maintained a Hold rating on Verifone (NYSE: PAY) on December 13

Cantor Fitzgerald Issues a Buy Rating on Aclaris Therapeutics Inc

Cantor Fitzgerald analyst Louise Chen assigned a Buy rating to Aclaris Therapeutics Inc (NASDAQ: ACRS) today and set a price target of $50. The company’s shares closed yesterday at $24.72. Chen wrote: “ACRS received approval for Eskata to treat SK.

Analysts Offer Insights on Healthcare Companies: Teva Pharma (NYSE: TEVA) and Orasure Technologies (NASDAQ: OSUR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teva Pharma (NYSE: TEVA) and Orasure Technologies (NASDAQ: OSUR). Teva Pharma (NYSE: TEVA) Raymond James analyst Elliot Wilbur assigned a Hold rating to

Guggenheim Believes Intersect ENT (NASDAQ: XENT) Still Has Room to Grow

In a report issued on December 11, Christopher Pasquale from Guggenheim reiterated a Buy rating on Intersect ENT (NASDAQ: XENT), with a price target of $41. The company’s shares closed yesterday at $31.85, close to its 52-week high of $34.40.